Overview XOMA is a royalty aggregator that plays a distinctive role in helping biotech companies achieve their goal of improving human health. We do this by providing capital in exchange for the economic rights to future milestone and royalty payments associated with clinical candidates and approved products. In return the drug developer or marketer receives non-dilutive, non-recourse funding. We seek to generate stockholder value by maintaining a diversified portfolio to mitigate single-asset, ...
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-18 | 2025-12-31 | 0001104659-26-030872 | EDGAR | 100K words |
| 2025-03-17 | 2024-12-31 | 0001558370-25-003131 | EDGAR | — |
| 2024-03-08 | 2023-12-31 | 0001558370-24-002782 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001558370-23-003259 | EDGAR | — |
| 2022-03-08 | 2021-12-31 | 0001558370-22-003022 | EDGAR | — |
| 2021-03-10 | 2020-12-31 | 0001558370-21-002676 | EDGAR | — |
| 2020-03-10 | 2019-12-31 | 0001558370-20-002286 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001564590-19-006621 | EDGAR | — |
| 2018-03-07 | 2017-12-31 | 0001564590-18-004731 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001564590-17-004563 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001104659-25-109782 | EDGAR | 48K words |
| 2025-08-13 | 2025-06-30 | 0001558370-25-011305 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001558370-25-007494 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001558370-24-014755 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001558370-24-011980 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007470 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001558370-23-017861 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001558370-23-013756 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001558370-23-008670 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001558370-22-016142 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001558370-22-012065 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0001558370-22-007241 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-18 | 0001193125-26-112338 | EDGAR | 6K words |
| 2026-03-02 | 0001193125-26-084016 | EDGAR | — |
| 2026-02-09 | 0001193125-26-042836 | EDGAR | — |
| 2026-01-15 | 0001193125-26-014142 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009726 | EDGAR | — |
| 2025-12-05 | 0001193125-25-308794 | EDGAR | — |
| 2025-11-21 | 0001193125-25-290638 | EDGAR | — |
| 2025-11-12 | 0001193125-25-275971 | EDGAR | — |
| 2025-10-03 | 0001193125-25-230466 | EDGAR | — |
| 2025-09-26 | 0001193125-25-220830 | EDGAR | — |
309 total filings indexed. 277 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000791908 |
| Ticker | XOMA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.xoma.com |
| Listed | 1986-06-06 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report